Obesity and hyperlipidemia are risk factors for early diabetic neuropathy

Journal of Diabetes and its Complications

Volumn 27, Issue 5, 2013, Pages 436-442

  Smith, A Gordon ^a   Singleton, J Robinson ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Hyperlipidemia; Obesity; Peripheral neuropathy

Indexed keywords

HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MOTOR NERVE CONDUCTION; NERVE CONDUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SKIN BIOPSY; TRIACYLGLYCEROL BLOOD LEVEL;

DIABETES; HYPERLIPIDEMIA; OBESITY; PERIPHERAL NEUROPATHY;

ADOLESCENT; ADULT; AGED; DIABETIC NEUROPATHIES; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; YOUNG ADULT;

EID: 84883791552     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2013.04.003     Document Type: Article

References (29)

1. J.W. Albers, and W.H. Herman Effect of prior intensive insulin treatment during the Diabetes Control And Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions, and Complications (EDIC) study Diabetes Care 33 5 2010 1090 1096
2. N. Azad, and N.V. Emanuele The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM) Journal of Diabetes and its Complications 13 5-6 1999 307 313
3. B.C. Callaghan, and E. Feldman Triglycerides and amputation risk in patients with diabetes: ten-year follow-up in the DISTANCE study Diabetes Care 34 3 2011 635 640
4. B.C. Callaghan, and J. Hur Diabetic neuropathy: one disease or two? Current Opinion in Neurology 25 5 2012 536 541
5. B.C. Callaghan, and A.A. Little Enhanced glucose control for preventing and treating diabetic neuropathy Cochrane Database of Systematic Reviews 6 2012 CD007543
6. E.P. Davidson, and L.J. Coppey Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction Diabetes/Metabolism Research and Reviews 26 4 2010 306 318
7. DCCT Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus The New England Journal of Medicine 329 1993 977 986
8. Diabetes Control and Complications Trial Research Group Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial Annals of Neurology 38 1995 869 880
9. W. Duckworth, and C. Abraira Glucose control and vascular complications in veterans with type 2 diabetes The New England Journal of Medicine 360 2 2009 129 139
10. P.J. Dyck, and J.E. Norell Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity Diabetes Care 30 10 2007 2619 2625
11. E.L. Feldman, and M.J. Stevens A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy Diabetes Care 17 1994 1281 1289
12. A. Gordois, and P. Scuffham The health care costs of diabetic peripheral neuropathy in the US Diabetes Care 26 6 2003 1790 1795
13. S.M. Grundy, and H.B. Brewer Jr. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation 109 3 2004 433 438
14. R.M. Herman, and J.B. Brower Prevalence of somatic small fiber neuropathy in obesity International Journal of Obesity 31 2 2007 226 235
15. R.A. Hughes, and T. Umapathi A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy Brain 127 Pt 8 2004 1723 1730
16. J. Hur, and K.A. Sullivan The identification of gene expression profiles associated with progression of human diabetic neuropathy Brain 134 PT 11 2011 3222 3235
17. F. Ismail-Beigi, and T. Craven Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial Lancet 376 9739 2010 419 430
18. G. Lauria, and M. Bakkers Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study Journal of the Peripheral Nervous System 15 3 2010 202 207
19. Lauria G, Hsieh ST. et al. (2010). European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. European Journal of Neurology 17(7): 903-912, e944-909.
20. I.G. Obrosova, and O. Ilnytska High-fat diet induced neuropathy of pre-diabetes and obesity: effects of healthy diet and aldose reductase inhibition Diabetes 56 10 2007 2598 2608
21. C.L. Oltman, and L.J. Coppey Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats American Journal of Physiology. Endocrinology and Metabolism 289 1 2005 E113 E122
22. J.R. Singleton, and B. Bixby The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy Journal of the Peripheral Nervous System 13 3 2008 218 227
23. A.G. Smith, and K. Rose Idiopathic neuropathy patients are at high risk for metabolic syndrome Journal of Neurological Sciences 273 1-2 2008 25 28
24. Standards of medical care in diabetes - 2011 Diabetes Care 34 Suppl 1 2011 S11 S61
25. S. Tesfaye, and A.J. Boulton Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments Diabetes Care 33 10 2010 2285 2293
26. S. Tesfaye, and N. Chaturvedi Vascular risk factors and diabetic neuropathy The New England Journal of Medicine 352 4 2005 341 350
27. The Expert Panel on Detection, E., and Treatment of High Blood Cholesterol in Adults, 2001 The Third Report of the ATP III. National Institutes of Health National Heart Lung and Blood Institute, Bethesda Maryland NIH publication 01-3670 http://www.nhlbi.nih.gov/guidelines/cholesterol/index.htm 2001
28. A.M. Vincent, and L.M. Hinder Hyperlipidemia: a new therapeutic target for diabetic neuropathy Journal of the Peripheral Nervous System 14 4 2009 257 267
29. T.D. Wiggin, and K.A. Sullivan Elevated triglycerides correlate with progression of diabetic neuropathy Diabetes 58 7 2009 1634 1640